A complaint-in-intervention filed in August 2022 alleged that Mr. Shah violated the False Claims Act by causing his labs to bill Medicare for expensive molecular tests that were not ordered by a medical provider. The following companies that Mr. Shah owns were also named in the complaint: United Diagnostics Lab, Tomoka Medical Lab, Tennessee Valley Regional Laboratory, Luminus Diagnostics and Golden Rule Management.
A district court on Sept. 21, 2023, granted the federal government’s motion for default judgment, awarding judgment in favor of the U.S. and against the defendants in the amount of:
– $105.6 million for Mr. Shah
– $6.2 million for Tomoka Medical Lab
– $24 million for Tennessee Valley Regional Laboratories
– $75.5 million for Luminus Diagnostics
– $105.6 million for Golden Rule Management
– $54.6 million for United Diagnostics Lab
Mr. Shah received a prison sentence in 2021 for a criminal contempt charge stemming from his violation of court orders related to the fraud investigation.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
